Putting disinfectants through their paces using Candida auris dry surface biofilm efficacy testing

Posted

Research

Candida auris is a high-profile emerging pathogen, which has caused large outbreaks both in the UK and elsewhere. C. auris can causes widespread environmental contamination, and isn’t susceptible to all disinfectants. This new study from Cardiff University extends previous findings by developing a dry surface biofilm efficacy testing model for C. auris. Worryingly, half of the disinfectants tested barely touched the C. auris in the DSB, suggesting that more powerful disinfectants (such as peracetic acid and sodium hypochlorite) should be selected for dealing with C. auris.

Previous studies have shown that a range of disinfectants are effective against C. auris when using conventional suspension testing methodology. However, we know from other studies that the presence of dry surface biofilm (DSB) can reduce the susceptibility of micro-organisms to disinfectants considerably. DSB occur when bacteria and other microbes become attached to surfaces and encased in a protective ‘slime’ layer: this can reduce their susceptibility to disinfectants by 10 to 1000-fold. Therefore, a team at Cardiff University developed a DSB model for C. auris disinfectant testing. 12 commercially-available wipe based disinfectants were tested. Concerning, 50% of the products tested failed to decrease C. auris viability, 58% failed to prevent its transferability, and 75% did not delay biofilm regrowth. Wipes that were effective in reducing C. auris viability and transferability included Clinell’s Universal Wipes, and Clinell’s Sporicidal Wipes (which are based on peracetic acid). Clinell’s Sporicidal Wipes were most effective at preventing re-growth of the biofilm.

This research reinforces that microbes in DSB are considerably less susceptible to disinfectants than microbes in suspension. Caution should be exercised in choosing the appropriate disinfectants for dealing with surfaces potentially contaminated with C. auris, with decisions informed by studies using DSB-based testing methods.

SHARE THIS ARTICLE

Tags

Latest News

Company News

GAMA Healthcare named one of The Sunday Times Best Places to Work 2026

National recognition celebrates GAMA’s exceptional culture, purpose-driven people and commitment to employee…

Research

Protecting vulnerable skin: New evidence highlights the role of structured skin care in preventing pressure injuries

A newly published randomised controlled trial has demonstrated that structured…

Research

Hantavirus at sea: Why the recent cruise ship outbreak matters for IPC

A recent hantavirus outbreak aboard an expedition cruise ship has…

Research

Beyond handrubs: Why QAC wipes could be the future of hand hygiene in challenging environments

Hand hygiene remains one of the most powerful tools in…